organization · Reporting owner
Apple Tree Partners II - Annex, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Rein Therapeutics, Inc.
Report date July 06, 2018 · Filed July 10, 2018
Section 16 reporting ended · disclosed 2018-07-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-07-06 · Other · Disposed 655,797 · Balance 0 F1: On July 6, 2018, Apple Tree Partners II - Annex, L.P. distributed 655,797 shares of the Issuer's Common Stock on a pro rata basis to its partners for no consideration. Following the distribution, Apple Tree Partners II - Annex, L.P. was no longer a holder of record of the Issuer's shares. F2: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II - Annex, L.P., and Dr. Harrison disclaims beneficial ownership of the shares previously held by Apple Tree Partners II - Annex, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison had sole voting and investment power over the shares previously held by Apple Tree Partners II - Annex, L.P. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 6, 2018, Apple Tree Partners II - Annex, L.P. distributed 655,797 shares of the Issuer's Common Stock on a pro rata basis to its partners for no consideration. Following the distribution, Apple Tree Partners II - Annex, L.P. was no longer a holder of record of the Issuer's shares.
F2: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II - Annex, L.P., and Dr. Harrison disclaims beneficial ownership of the shares previously held by Apple Tree Partners II - Annex, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison had sole voting and investment power over the shares previously held by Apple Tree Partners II - Annex, L.P.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2018 Filed Jul 10, 2018 20:27 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | OtherCommon Stock | 655,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000907 · edgar.xml · nonDerivative · entry 1 Apple Tree Partners II - Annex, L.P. · CIK 0001553255 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On July 6, 2018, Apple Tree Partners II - Annex, L.P. distributed 655,797 shares of the Issuer's Common Stock on a pro rata basis to its partners for no consideration. Following the distribution, Apple Tree Partners II - Annex, L.P. was no longer a holder of record of the Issuer's shares. F2 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II - Annex, L.P., and Dr. Harrison disclaims beneficial ownership of the shares previously held by Apple Tree Partners II - Annex, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison had sole voting and investment power over the shares previously held by Apple Tree Partners II - Annex, L.P. Read SEC document |
| July 05, 2017 Filed Jul 8, 2017 00:31 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries E-1 Preferred Stock · Derivative | 3,026,920 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018104 · doc4.xml · derivative · entry 3 Apple Tree Partners II - Annex, L.P. · CIK 0001553255 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 304,611 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series E and Series E-1 Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series E and Series E-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: The Series E and Series E-1 Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series E and Series E-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: The Series E and Series E-1 Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series E and Series E-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II-Annex, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II-Annex, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II-Annex, L.P. Read SEC document |
| July 05, 2017 Filed Jul 8, 2017 00:31 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries E Preferred Stock · Derivative | 3,489,740 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018104 · doc4.xml · derivative · entry 2 Apple Tree Partners II - Annex, L.P. · CIK 0001553255 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 351,186 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series E and Series E-1 Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series E and Series E-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: The Series E and Series E-1 Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series E and Series E-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: The Series E and Series E-1 Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series E and Series E-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II-Annex, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II-Annex, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II-Annex, L.P. Read SEC document |
| July 05, 2017 Filed Jul 8, 2017 00:31 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionCommon Stock | 655,797 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-018104 · doc4.xml · nonDerivative · entry 1 Apple Tree Partners II - Annex, L.P. · CIK 0001553255 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series E and Series E-1 Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series E and Series E-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II-Annex, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II-Annex, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II-Annex, L.P. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.